In Alzheimer’s disease (AD), TREM2 plays a protective role, and its overexpression is associated with the removal of soluble and insoluble Aβ42 aggregates from the brain (Lessard et al., 2018). Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.